BLIS Technologies Ltd
NZX:BLT

Watchlist Manager
BLIS Technologies Ltd Logo
BLIS Technologies Ltd
NZX:BLT
Watchlist
Price: 0.015 NZD -6.25% Market Closed
Market Cap: 19.2m NZD
Have any thoughts about
BLIS Technologies Ltd?
Write Note

BLIS Technologies Ltd
Investor Relations

BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce Bacteriocin activity. The company is headquartered in Dunedin, Otago. The company went IPO on 2001-07-30. The firm is also engaged in supply of healthcare ingredients and the manufacture of part and finished goods and food products for sale in domestic and international markets. The firm supplies BLIS-branded finished goods. The firm's products include BLIS K12 and BLIS M18, which are oral probiotics providing protection for ear, nose and throat health, halitosis (bad breath), gums and teeth health and immune support. The firm distributes its products through Stratum Nutrition in North America, NZPR Group in China, and Bluestone Pharma in Europe and Middle East. Its other BLIS branded products include Throat Guard EVERYDAY BLIS K12, Travel Guard BLIS K12, Fresh Breath Kit K12 and Toddler Protect BLIS K12 Powder for Toddlers.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Scott Ogilvie Johnson B.Com., CMINSTD, M.B.A.
Chief Executive Officer
No Bio Available
Mr. Richard Wingham B.Com., C.A.
Chief Financial Officer
No Bio Available
Dr. John David-Francis Hale BSc (Hons), Ph.D.
Chief Technology Officer
No Bio Available
Jennifer Walker B.A., M.B.A.
Chief Revenue Officer
No Bio Available
Melissa Drysdale B.A.
Head of Quality
No Bio Available

Contacts

Address
OTAGO
Dunedin
81 Glasgow Street
Contacts
+6434740988.0
blis.co.nz